Search by Drug Name or NDC
NDC 53002-1704-01 Clindamycin Phosphate 10 mg/mL Details
Clindamycin Phosphate 10 mg/mL
Clindamycin Phosphate is a TOPICAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is CLINDAMYCIN PHOSPHATE.
MedlinePlus Drug Summary
Topical clindamycin is used to treat acne. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria that cause acne and by decreasing swelling.
Related Packages: 53002-1704-01Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Clindamycin Topical
Product Information
| NDC | 53002-1704 |
|---|---|
| Product ID | 53002-1704_ceb68353-890f-4124-aecd-912c79430081 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clindamycin Phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clindamycin Phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Labeler Name | RPK Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065049 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1704-01 (53002170401)
| NDC Package Code | 53002-1704-1 |
|---|---|
| Billing NDC | 53002170401 |
| Package | 60 mL in 1 BOTTLE (53002-1704-1) |
| Marketing Start Date | 2022-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |